Does the -ib medication suffix have meaning? I know -ab medications like Benralizumab, Canakinumab, etc are monoclonal antibodies. The only -ib I can remember other than this new one is Imatinib, which is also a cancer treatment, so maybe it's to do with cancer?
The suffix -ib stands for inhibitor, but it's
not a standalone suffix as such.
In this case the "real" suffix is -rasib, meaning RAS inhibitor. This is the "stem" defined by the WHO [1].
You have other suffixes like -coxib (for COX inhibitors like celecoxib) and -nib (for kinase inhibitors like upadacitinib, where -citinib then refers to JAK/TYK type kinase).
Itβs a category called small-molecule drug. I take a medication called upadacitinib for ulcerative colitis. Previously, I took monoclonal antibodies called Ustekinumab and vedolizumab.
These medication-categories are not only prevalent in cancer therapy.
If you look at the molecular size, -ibs are very small and -mabs really huge.